Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Exon Recombination

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...

General Transcription Factors

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

TDP-43 dysfunction facilitates the pathological conversion of tau.

Molecular neurodegeneration·2026

Same author

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.

JAMA neurology·2026

Same author

BCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice.

bioRxiv : the preprint server for biology·2026

Same author

Tauopathy primes co-filament assembly and dysfunction of TDP-43.

bioRxiv : the preprint server for biology·2026

Same author

TDP-43: [GU]-ardian of the transcriptome.

Molecular neurodegeneration·2026

Same author

Machine learning model based on plasma proteomics for the identification of Parkinson's disease.

Brain : a journal of neurology·2026

Same journal

The human LRRK2-R1441G mutation drives age-dependent oxidative stress and mitochondrial dysfunction in dopaminergic neurons.

Molecular neurodegeneration·2026

Same journal

Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice.

Molecular neurodegeneration·2026

Same journal

Standardized protocol to detect phosphorylated α-synuclein in skin biopsies: recommendations from an expert panel.

Molecular neurodegeneration·2026

Same journal

A 'Tangled Web' in the CNS: unraveling neutrophil extracellular traps in neurological disorders.

Molecular neurodegeneration·2026

Same journal

Perspective of retinal Chlamydia pneumoniae infection in Alzheimer's disease pathogenesis.

Molecular neurodegeneration·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Tdp-43 cryptic exons are highly variable between cell types.

Yun Ha Jeong^1,2, Jonathan P Ling¹, Sophie Z Lin¹

¹Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

Molecular Neurodegeneration

|February 4, 2017

Summary

This summary is machine-generated.

TDP-43 loss impacts cell-specific pathways. Researchers found that TDP-43 (TAR DNA-binding protein 43) loss of function leads to cell type-specific cryptic exons, potentially affecting unique molecular pathways in brain and muscle diseases.

Keywords:

Amyotrophic lateral sclerosis Bioinformatics Frontotemporal dementia Inclusion body myositis TDP-43 –Nonconserved cryptic exons

More Related Videos

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Experiment Videos

Last Updated: Mar 8, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Area of Science:

Molecular Biology
Neuroscience
Genetics

Background:

TDP-43 proteinopathy is implicated in neurodegenerative diseases like ALS and FTD.
TDP-43 normally represses nonconserved cryptic exons.
The study explores cell type-specific cryptic exons arising from TDP-43 dysfunction.

Purpose of the Study:

To investigate the cell type-specific functions of TDP-43 in mouse models.
To identify cryptic exons associated with TDP-43 loss of function in different cell types.
To understand how TDP-43 dysfunction impacts unique molecular pathways.

Main Methods:

Generated genetically modified mice with conditional TDP-43 deletion in excitatory neurons and skeletal myocytes.
Analyzed TDP-43's role in various mouse tissues.
Identified cell type-specific cryptic exons using comparative analysis.

Main Results:

Loss of TDP-43 function leads to the identification of cell type-specific cryptic exons.
While some cryptic exons were common across cell types, most were unique to specific cell types like neurons and myocytes.
This highlights the cell-specific nature of TDP-43's regulatory role.

Conclusions:

TDP-43 loss of function may impair distinct cell type-specific pathways in human diseases.
These findings suggest a mechanism for TDP-43's contribution to the pathogenesis of diseases like ALS, FTD, and IBM.
Understanding cell-specific effects is crucial for developing targeted therapies.